Absence of exon 15 BRAF germline mutations in familial melanoma

Human Mutation

Volumn 21, Issue 3, 2003, Pages 327-330

  Lang, Julie ^a   Boxer, Maureen ^a   MacKie, Rona ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

BRAF; Cancer; CDKN2A; MCIR; Melanoma, familial; Tumor

Indexed keywords

GLUTAMIC ACID; VALINE;

ADULT; AGED; ARTICLE; BRAF GENE; CARCINOGENESIS; CLINICAL ARTICLE; DNA DETERMINATION; EXON; FAMILIAL CANCER; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MELANOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FAMILY HEALTH; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION, MISSENSE; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 0037222652     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10188     Document Type: Article

References (8)

1. Bishop DT, Demenais F, Goldstein AM, Bergman W, Newton Bishop J, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA. 2002. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 94:894-903.
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949-954.
3. Elwood JM, Jopson J. 1997. Melanoma and sun exposure: an overview of published studies. Int J Cancer 73:198-203.
4. Jemal A, Devesa SS, Hartge P, Tucker MA. 2001. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93:678-683.
5. MacKie RM, Andrew N, Lanyon WG, Connor JM. 1998. CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas. J Invest Dermatol. 111:269-72.
6. MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, Doherty V, Vestey J. 2002. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 360:587-591.
7. Marrett LD, Nguyen HL, Armstrong BK. 2001. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 92:457-462.
8. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA. 2000. Melano-cortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66:176-186.